Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data

Höglinger, Marc; Wirth, Brigitte; Carlander, Maria; Caviglia, Cornelia; Frei, Christian; Rhomberg, Birgitta; Rohrbasser, Adrian; Trottmann, Maria; Eichler, Klaus

doi:10.1007/s10198-022-01486-2

Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-25341

Publication type:	Article in scientific journal
Type of review:	Peer review (publication)
Title:	Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data
Authors:	Höglinger, Marc Wirth, Brigitte Carlander, Maria Caviglia, Cornelia Frei, Christian Rhomberg, Birgitta Rohrbasser, Adrian Trottmann, Maria Eichler, Klaus
et. al:	No
DOI:	10.1007/s10198-022-01486-2 10.21256/zhaw-25341
Published in:	The European Journal of Health Economics
Volume(Issue):	24
Issue:	3
Page(s):	469
Pages to:	478
Issue Date:	18-Jun-2022
Publisher / Ed. Institution:	Springer
ISSN:	1618-7601 1618-7598
Language:	English
Subjects:	Diabetes; Disease management; Primary care; Program evaluation; Quality of care; Structured treatment program
Subject (DDC):	362.1041: Health economics 616: Internal medicine and diseases
Abstract:	Objective: To evaluate the impact of a DMP for patients with diabetes mellitus in a Swiss primary care setting. Methods: In a prospective observational study, we compared diabetes patients in a DMP (intervention group; N?=?538) with diabetes patients receiving usual care (control group; N?=?5050) using propensity score matching with entropy balancing. Using a difference-in-difference (DiD) approach, we compared changes in outcomes from baseline (2017) to 1-year (2017/18) and to 2-year follow-up (2017/19). Outcomes included four measures for guideline-adherent diabetes care, hospitalization risk, and health care costs. Results: We identified a positive impact of the DMP on the share of patients fulfilling all measures for guideline-adherent care [DiD 2017/18: 7.2 percentage-points, p?<?0.01; 2017/19: 8.4 percentage-points, p?<?0.001]. The hospitalization risk was lower in the intervention group in both years, but only statistically significant in the 1-year follow-up [DiD 2017/18: – 5.7 percentage-points, p?<?0.05; 2017/19: – 3.9 percentage points, n.s.]. The increase in health care costs was smaller in the intervention than in the control group [DiD 2017/18: CHF – 852; 2017/19: CHF – 909], but this effect was not statistically significant. Conclusion: The DMP under evaluation seems to exert a positive impact on the quality of diabetes care, reflected in the increase in the measures for guideline-adherent care and in a reduction of the hospitalization risk in the intervention group. It also might reduce health care costs, but only a longer follow-up will show whether the observed effect persists over time.
URI:	https://digitalcollection.zhaw.ch/handle/11475/25341
Fulltext version:	Published version
License (according to publishing contract):	CC BY 4.0: Attribution 4.0 International
Departement:	School of Management and Law
Organisational Unit:	Winterthur Institute of Health Economics (WIG)
Appears in collections:	Publikationen School of Management and Law

Files in This Item:

File	Description	Size	Format
2022_Hoeglinger-etal_Impact-diabetes-disease-management.pdf		551.4 kB	Adobe PDF	View/Open

Show full item record

Höglinger, M., Wirth, B., Carlander, M., Caviglia, C., Frei, C., Rhomberg, B., Rohrbasser, A., Trottmann, M., & Eichler, K. (2022). Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data. The European Journal of Health Economics, 24(3), 469–478. https://doi.org/10.1007/s10198-022-01486-2

Höglinger, M. et al. (2022) ‘Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data’, The European Journal of Health Economics, 24(3), pp. 469–478. Available at: https://doi.org/10.1007/s10198-022-01486-2.

M. Höglinger et al., “Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data,” The European Journal of Health Economics, vol. 24, no. 3, pp. 469–478, Jun. 2022, doi: 10.1007/s10198-022-01486-2.

HÖGLINGER, Marc, Brigitte WIRTH, Maria CARLANDER, Cornelia CAVIGLIA, Christian FREI, Birgitta RHOMBERG, Adrian ROHRBASSER, Maria TROTTMANN und Klaus EICHLER, 2022. Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data. The European Journal of Health Economics. 18 Juni 2022. Bd. 24, Nr. 3, S. 469–478. DOI 10.1007/s10198-022-01486-2

Höglinger, Marc, Brigitte Wirth, Maria Carlander, Cornelia Caviglia, Christian Frei, Birgitta Rhomberg, Adrian Rohrbasser, Maria Trottmann, and Klaus Eichler. 2022. “Impact of a Diabetes Disease Management Program on Guideline-Adherent Care, Hospitalization Risk and Health Care Costs : A Propensity Score Matching Study Using Real-World Data.” The European Journal of Health Economics 24 (3): 469–78. https://doi.org/10.1007/s10198-022-01486-2.

Höglinger, Marc, et al. “Impact of a Diabetes Disease Management Program on Guideline-Adherent Care, Hospitalization Risk and Health Care Costs : A Propensity Score Matching Study Using Real-World Data.” The European Journal of Health Economics, vol. 24, no. 3, June 2022, pp. 469–78, https://doi.org/10.1007/s10198-022-01486-2.